Sequenom to Present at 7th Annual Needham & Company Biotechnology & Medical Technology Conference

Sequenom, Inc. (NASDAQ: SQNM), a leading provider of genetic analysis solutions, today announced that Harry Stylli, Ph.D., President and Chief Executive Officer, is scheduled to present at the 7th Annual Needham & Company Biotechnology & Medical Technology Conference on Thursday, June 12th at 11:00 a.m. Eastern time (8:00 a.m. Pacific time). The conference is being held at The New York Palace Hotel in New York City.

A live webcast of the presentation will be available on the Company's Web site at www.sequenom.com, and replays will be available for 14 days starting approximately three hours after the initial presentation.

About Sequenom

Sequenom is committed to providing the best genetic analysis products for research and the molecular diagnostic markets. The Company makes available superior solutions for genomic science in biomedical research, livestock and agricultural applications and molecular medicine, as well as for various diagnostic markets, including noninvasive prenatal testing, oncology and infectious diseases. Sequenom's proprietary MassARRAY(R) system delivers reliable and specific data from complex biological samples and from genetic target materials available only in trace amounts.

Sequenom(R) and MassARRAY(R) are trademarks of Sequenom, Inc.

SOURCE: Sequenom, Inc.

Company Contact
Sequenom, Inc.
Paul W. Hawran, Chief Financial Officer, 858-202-9000
or
Investor Relations Contact
Lippert/Heilshorn & Associates
Jody Cain, 310-691-7100
jcain@lhai.com

Related terms: agricultural, biomedical, biotechnology, ceo, conference, hotel, livestock, medical, medicine, nasdaq, new york, president, products, research, science, technology, web